Vycor Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Vycor Medical Inc 's inventory turnover ratio sequentially decreased to 1.72 in the second quarter 2026, otherwise the ratio remained above the average, as VYCO's markets remain strong.Vycor Medical Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 212 days, from 197 days, in the Mar 31 2026 quarter.

Within Healthcare sector 229 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1290 in the first quarter 2026, to 1592.

VYCO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vycor Medical Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VYCO Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	22.09 %	3.14 %	-28.35 %	-10.77 %	-28.53 %
Y / Y Cost of Sales Growth	-8.96 %	7.12 %	40.91 %	68.12 %	130.59 %
Inventory Turnover Ratio (TTM)	1.72	1.85	1.83	1.54	1.37
VYCO's Total Ranking	# 1592	# 1290	# 1457	# 1442	# 1568
Average inventory processing period	212	197	199	236	267
Seq. Inventory Growth	4.73 %	14.26 %	-4.91 %	7.29 %	-11.53 %
Seq. Cost of Sales Growth	-11.47 %	2.31 %	31.76 %	-23.71 %	4.16 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 101
Healthcare Sector	# 230
Overall Market	# 1592

Inventory Turnover Ratio Statistics
High	Average	Low
1.85	0.79	0.41
(Mar 31 2026)		(Jun 30 2013)

VYCO Company Profile >> Back to VYCO Efficiency Comparisons >> Compare VYCO Inventory Turnover Ratio to its Competitors

Financial Statements
Vycor Medical Inc 's Inventories	$ 0 Millions	Visit VYCO's Balance sheet
Vycor Medical Inc 's Cost of Revenues TTM	$ 0 Millions	Visit VYCO's Income Statement
What are VYCO's Sales?		Visit VYCO's Sales by Segment

Other Inventory Turnover Ratios
Vycor Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VYCO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VYCO's Competitors
Inventory Turnover Ratio for VYCO's Suppliers
Inventory Turnover Ratio for VYCO's Customers

You may also want to know
VYCO's Sales Growth Rates	VYCO's Pe Price to earnings ratio	VYCO's Receivables Turnover Ratio	VYCO's Stock Quote
VYCO's Net Income Growth Rates	VYCO's Ps Price to Sales ratio	VYCO's Sales per Employee	VYCO's Asset Turnover Ratio
VYCO's Net Margin	VYCO's Pb Price to Book ratio	VYCO's Financial Strength Ratios	VYCO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Vericel Corporation	4.30	$ 77.922 Millions	$ 18 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Coherus Oncology inc	4.03	$ 15.822 Millions	$ 4 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Abbvie Inc	3.66	$ 18,365.000 Millions	$ 5,016 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Baxter International Inc	3.46	$ 8,020.000 Millions	$ 2,317 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions

Date modified: 2026-08-16T05:14:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.